The Latest Cardiac and Vascular News
• Strong Fourth Quarter China Roxadustat Net Sales of $29.2 Million and 2020 full-year Net Sales of $72.5 Million • FDA to hold Advisory Committee Meeting on Roxadustat New Drug Application SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the fourth quarter […]
– Record Fourth Quarter 2020 Revenues Increase 31% to $12.8 Million – – U.S. WatchPAT™ Revenues Increase 39% to $10.2 Million – – Full Year 2021 Revenue Guidance of $52 Million and $53 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT – CAESAREA, Israel, March 02, 2021 (GLOBE NEWSWIRE) […]
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical […]
Introducing a mammal-derived genome engineering enzyme for next-generation gene and cell therapy Financing to fund SalioGen’s pipeline in genetic diseases, based on proprietary EDIT ‘gene coding’ platform to advance durable, safe and affordable non-viral gene therapies Financing concurrent with strengthening of board of directors and scientific advisory board BURLINGTON, Mass., […]
CHICAGO, March 1, 2021 /PRNewswire/ — Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021. On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published new Category 1 reimbursement rates applicable to the Current Procedural Terminology (CPT) codes for the […]
RADNOR, Pa., Feb. 27, 2021 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP reminds iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) investors that a securities fraud class action lawsuit has been filed against iRhythm on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive […]
NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the Advanced Medical Technology Association (AdvaMed), the world’s leading medical technology trade association, has appointed Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive […]
Record Quarterly Revenue of $29.3 million in Q4 2020, up 149% year over year and up 22% from Q3 2020 Operating loss of $1.8 million in Q4 2020, a 74% improvement year over year Record Quarterly Adjusted EBITDA of $2.2 million in Q4 2020, achieving quarterly positive Adjusted EBITDA for […]
Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group, Casdin Capital and GV. Funds will help advance lead gene therapy program in hypertrophic […]
Reflects Company’s Evolution to Offering Digital Health Framework Complementing its Capital Equipment Technologies IRVINE, Calif.–(BUSINESS WIRE)–Nihon Kohden, a U.S. market leader in precision medical products and services, today announced that it is rebranding Nihon Kohden USLab, its Irvine-based R&D and product development subsidiary, to Nihon Kohden Digital Health Solutions Inc. […]
